Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma (PREMIER)
This study has been terminated.
(Terminated by sponsor due to low enrollment; see details below)
Genzyme, a Sanofi Company
First Posted: March 29, 2006
Last Update Posted: December 27, 2013
Information provided by (Responsible Party):
Sanofi ( Genzyme, a Sanofi Company )